Multiple Myeloma Cells with Increased Proteasomal and ER Stress Are Hypersensitive to ATX-101, an Experimental Peptide Drug Targeting PCNA

Camilla Olaisen(Norwegian University of Science and Technology), Marit Otterlei(Norwegian University of Science and Technology)
Cancers
November 26, 2024
Cited by 2


Related Papers